CROI 2017 Program and Information

Program and Agenda

Poster P-O9 RENAL DISEASE Poster Hall - 4 EF 2:30 PM - 4:00 PM 686 PREVALENCE AND RISK FACTORS OF RENAL INJURY IN OPTION B+DURING THE FIRST 6MONTHS Caroline Melhado , Jacob Phulusa, Mathius John, Allan Jumbe, Bryna Harrington, Bryan Mthiko, Mina C. Hosseinipour, for the S4 Team Univ of North Carolina Proj–Malawi, Lilongwe, Malawi 687 PREDICTORS OF CKD AND UTILITY OF RISK-PREDICTION SCORES INHIV-POSITIVE INDIVIDUALS Emily Woolnough 1 , Jennifer Hoy 1 , Allen Cheng 1 , Rowan G. Walker 1 , Anastasia Chrystostomou 1 , Ian Woolley 1 , Freya Langham 1 , Michael Moso 1 , Achini Weeraratne 2 , Janine M. Trevillyan 1 1 Alfred Hosp, Melbourne, Australia, 2 Monash Univ, Melbourne, Australia

Poster P-P10 NEUROSYPHILIS Poster Hall - 4 EF

2:30 PM - 4:00 PM

749 HOWWELL DO NEUROLOGIC SYMPTOMS IDENTIFY HIV- INFECTED INDIVIDUALSWITHNEUROSYPHILIS?

Arielle P. Davis 1 , Joshua Stern 2 , Shelia Dunaway 1 , Lauren Tantalo 1 , Sharon Sahi 1 , Abigail Crooks 1 , Claire Stevens 1 , Sarah Holte 3 , Christina Marra 1 1 HarborviewMed Cntr, Seattle, WA, USA, 2 Univ of Washington, Seattle, WA, USA, 3 FRCHC, Seattle, WA, USA

750 TREATMENT OF NEUROSYPHILIS: IV PENICILLIN G VS IM PROCAINE PENICILLIN/ORAL PROBENECID

Shelia Dunaway 1 , Claire Maxwell 2 , Lauren Tantalo 1 , Sharon Sahi 1 , Arielle P. Davis 1 , Claire Stevens 1 , Abigail Crooks 1 , Christina Marra 1 1 HarborviewMed Cntr, Seattle, WA, USA, 2 Univ of Washington, Seattle, WA, USA

Poster P-P11 PROTOZOAL OIs Poster Hall - 4 EF

2:30 PM - 4:00 PM

751 STOPPING SECONDARY TE PROPHYLAXIS IN SUPPRESSED PATIENTSWITH CD4 100-200 IS NOT SAFE Jose M. Miro , for the Opportunistic Infection Team of the COHERE in EuroCoord IDIBAPS, Barcelona, Spain 752 ASYMTOMATIC INFECTION IN ANHIV COHORT: LEISHMANIASIS OUTBREAK IN FUENLABRADA, SPAIN Alicia Castro 1 , Eugenia Carrillo 2 , Juan V. San Martin 1 , Laura Botana 2 , Laura Molina 1 , Laura Fernandez 2 , Belen Matia 1 , Carmen Sanchez 2 , Jose Manuel Ruiz-Giardin 1 , Javier Moreno 2 1 Hosp Univ de Fuenlabrada, Fuenlabrada, Madrid, Spain, 2 Inst de Salud Carlos III, Majadahonda, Spain

Poster Sessions • Thursday

CROI 2017 192